Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
The Latest in RSV Protection for Kids: An Antibody Treatment Called Beyfortus
2023
· Johns Hopkins University
This article describes a new drug called Beyfortus that helps protect babies and toddlers from RSV, a virus causing serious illness in young children. Approved …
Ask aRCie
The Burden of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Synthesis
This article discusses the significant burden of respiratory syncytial virus (RSV) in infants in the United States. It covers the epidemiology, hospitalization rates, mortality, costs, …
RSV Prevention Options for Infants and Older Adults: A Specific Expanding Competitive Arena
This article focuses on respiratory syncytial virus (RSV), a common virus that can be serious for infants and older adults. It describes new ways to …
Preventing Respiratory Syncytial Virus (RSV) Disease in Children
2021
· Johns Hopkins University
This brief perspective article discusses the progress and promising strategies for RSV immunization to combat the significant burden of RSV infection in young children globally. …
Advocate to Vaccinate: Moving Away From the "Politics" of Vaccination
2024
· New York Medical College
This policy commentary focuses on promoting vaccines without political influence. It describes efforts to encourage vaccination, especially for children, while avoiding political debates that can …
Respiratory Syncytial Virus Prevention: A New Era of Vaccines
2023
· Jiangsu University,
· University of Massachusetts,
· Mayo Clinic,
· Johns Hopkins University,
· Rochester Regional Health,
· Mir Neurology
This editorial discusses new vaccines for preventing respiratory syncytial virus (RSV) infections. RSV affects the lungs and can be serious, especially in young children and …
Cost-Effectiveness Analysis of Nirsevimab and Maternal Rsvpref Vaccine Strategies for Prevention of Respiratory Syncytial Virus Disease Among Infants in Canada: A Simulation Study
2023
· Yale University,
· York University,
· Dalhousie University
This study in Canada assessed cost-effectiveness of nirsevimab and RSVpreF for preventing RSV in infants. Modeling different interventions showed immunizing the birth cohort with nirsevimab …
Preventing Respiratory Syncytial Virus in Children in France: A Narrative Review of the Importance of a Reinforced Partnership Between Parents, Healthcare Professionals, and Public Health Authorities
This article describes the importance of preventing respiratory syncytial virus (RSV) in young children in France. It highlights the need for a strong partnership between …
Game Over for RSV?
2023
· Yale University
This letter comments on a study by D. Wilkins and colleagues and concludes that passive immunization with nirsevimab protects infants from severe respiratory syncytial virus …
Evaluation of Antibody-Based Preventive Alternatives for Respiratory Syncytial Virus: A Novel Multi-Criteria Decision Analysis Framework and Assessment of Nirsevimab in Spain
2024
· University Carlos III,
· BioMad,
· Fisabio-Public Health,
· Catholic University of Valencia,
· Instituto de Salud Carlos III,
· Weber Foundation
This study evaluates nirsevimab, an antibody-based preventive measure for respiratory syncytial virus (RSV) in Spain. Using a multi-criteria decision analysis framework, experts found that nirsevimab …